 |
 |
Ray, could you please e-mail me the name of that person in Murietta, CA? I used to be the acting postmaster there. I was the Postmaster in Lake Elsinore (15 miles away) when Parkinsons forced me to retire early also. Claudia -----Original Message----- From: Parkinson's Information Exchange Network [mailto:[log in to unmask]] On Behalf Of rayilynlee Sent: Sunday, October 22, 2006 10:00 AM To: [log in to unmask] Subject: Re: New tremor drug -- "T2000" Tremor was my worst and most disabling symptom until my 2 DBS surgeries in 2003. It is my understanding that it is the most difficult symptom of PD to treat. A postal worker in Murietta CA was taking Mirapex which stopped hers for a year, then the tremor took over any way. She had to retire early. Ray ----- Original Message ----- From: "ariela" <[log in to unmask]> To: <[log in to unmask]> Sent: Saturday, October 21, 2006 8:12 AM Subject: Re: New tremor drug -- "T2000" here are some related links re. 'T2000' (apparently, the currently-proper name of the drug whose chemical compound is '1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid'). http://phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-newsArticle&ID=917 863&highlight= http://www.pipelinereview.com/joomla/content/view/3330/113/ http://today.reuters.com/news/articleinvesting.aspx?view=PR&symbol=TARO.O&st oryID=236744+15-May-2006+BW&type=qcna http://www.taro.com/NewsArchive/2002/PR_T2000_Patent/press.aspx -- as you can see, development of 'T2000' has been in the works since well before 2002.... cheers, ariela ----- Start Original Message ----- Sent: Fri, 20 Oct 2006 10:40:55 -0700 From: rayilynlee <[log in to unmask]> To: [log in to unmask] Subject: Re: New tremor drug > All I can get from this is T2000. Not too helpful. > ----- Original Message ----- > From: "ds401" <[log in to unmask]> > To: <[log in to unmask]> > Sent: Thursday, October 19, 2006 5:16 AM > Subject: Re: New tremor drug > > > > what is the name of the drug ? > > thanks > > > > rayilynlee wrote: > > > >> NEW YORK (AFX) - Israeli drug developer Taro Pharmaceutical > >> Industries Ltd. > >> said Wednesday it received a U.S. patent for its non-sedating > >> barbiturate compounds aimed at treating essential tremor and > >> Parkinson's disease. > >> The patent expires in June 2025. > >> One compound, called T2000, is in a mid-stage clinical trial in > >> Canada for the treatment of moderate to severe essential tremor. > >> More than six million Americans suffer from both essential tremor > >> and Parkinson's disease, Taro said. Copyright 2006 Associated > >> Press. All rights reserved. This material may not be published, > >> broadcast, rewritten, or redistributed. > >> Production or sales statistics > >> Government regulatory actions > >> ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn